StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Wolfe Research Reiterates Underperform Rating on Medtronic, Inc. (MDT)
August 21, 2024 5:13 AM
Wolfe Research analyst Mike Polark reiterated an Underperform rating and $82.00 price target on Medtronic, Inc. (NYSE: MDT).The analyst comments ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Next Articles
Medtronic, Inc. (MDT) PT Raised to $90 at Truist Securities
August 22, 2024 12:16 PM
Goldman Sachs Reiterates Sell Rating on Medtronic, Inc. (MDT)
August 21, 2024 6:52 AM
Medtronic, Inc. (MDT) PT Raised to $94 at Oppenheimer
August 21, 2024 6:48 AM
Medtronic, Inc. (MDT) PT Raised to $106 at Wells Fargo
August 21, 2024 5:19 AM
Deutsche Bank Reiterates Hold Rating on Medtronic, Inc. (MDT)
August 21, 2024 5:10 AM
Medtronic, Inc. (MDT) PT Raised to $87 at Stifel
August 20, 2024 3:56 PM
Needham Reiterates Hold Rating on Medtronic, Inc. (MDT)
August 20, 2024 12:15 PM
TD Cowen Reiterates Buy Rating on Medtronic, Inc. (MDT)
August 20, 2024 10:33 AM
Midday movers: Lilly, Palo Alto and Fabrinet rise; Lowe's, Boeing fall
August 20, 2024 7:19 AM
Medtronic nudges profit forecast on medical devices demand, new launches
August 20, 2024 7:02 AM
Medtronic hikes fiscal 2025 guidance as Q1 earnings beat expectations
August 20, 2024 7:01 AM
Medtronic (MDT) Tops Q1 EPS by 3c, Offers FY25 EPS Guidance
August 20, 2024 6:48 AM
Form 8-K Medtronic plc For: Aug 20
August 20, 2024 6:47 AM
Medtronic reports first quarter fiscal 2025 financial results
August 20, 2024 6:45 AM
Form 4 Medtronic plc For: Aug 15 Filed by: Corona Gary Louis
August 19, 2024 4:21 PM
Medtronic (MDT) call put ratio 2.5 calls to 1 put into quarter results
August 19, 2024 11:16 AM
